4//SEC Filing
Wallace Noel R. 4
Accession 0001225208-24-002020
CIK 0000021665other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:11 PM ET
Size
11.2 KB
Accession
0001225208-24-002020
Insider Transaction Report
Form 4
Wallace Noel R.
Pres.- Colgate U.S.
Transactions
- Exercise/Conversion
Common Stock
2024-02-12$68.16/sh+50,000$3,408,000→ 324,179 total - Sale
Common Stock
2024-02-12$83.15/sh−50,000$4,157,280→ 274,179 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-12−50,000→ 55,486 totalExercise: $68.16Exp: 2024-09-13→ Common Stock (50,000 underlying)
Holdings
- 51,697(indirect: By Trust)
Common Stock
- 52,000(indirect: By Trust)
Common Stock
- 335(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.
- [F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.
- [F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $82.87 to $83.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2018 grant date.
Documents
Issuer
COLGATE PALMOLIVE CO
CIK 0000021665
Entity typeother
Related Parties
1- filerCIK 0001464265
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:11 PM ET
- Size
- 11.2 KB